Immunocidin 5ml

Mycobacterium phlei cell wall/DNA complex immunostimulant for intra-lesional treatment of equine sarcoids. Mycobacterium phlei cell wall-nucleic acid complex (MCNA) immunostimulant. Mechanism: TLR activation via mycobacterial cell wall components (lipoarabinomannan, peptidoglycan, CpG DNA) → macrophage and NK cell activation → local cytokine induction → anti-tumor immune response at injection site. Intra-lesional injection into equine sarcoids. Key information Mycobacterium cell wall immunostimulant for equine sarcoid/melanoma. Intralesional injection. Refrigerate. Inflammatory response expected. Multiple treatments required.

Intratumoral injection: administer directly into tumor tissue using sterile technique and appropriate needle length to reach tumor center. Administer weekly for 3–5 treatments. Store refrigerated (2–8°C); do not freeze. If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

Intratumoral injection: local inflammatory response (erythema, swelling, necrosis — expected anti-tumor effect). Fever, lethargy. Immune activation reactions. Scarring at treated site.

For animals Intratumoral injection — administer strictly intratumorally; avoid peritumoral injection. Aseptic technique required. Monitor for systemic immune reactions. For people handling this medication Administered by veterinary professionals only. No specific human precautions for caregivers beyond normal hygiene.

Contact your veterinarian. Intralesional immunostimulant — overdose causes excessive local inflammation. Managed by veterinary staff.